rs114849139
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 2P and 13B. PM1BP4_StrongBP6BS1BS2
The NM_004646.4(NPHS1):āc.2869G>Cā(p.Val957Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000648 in 1,614,168 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_004646.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPHS1 | NM_004646.4 | c.2869G>C | p.Val957Leu | missense_variant | 21/29 | ENST00000378910.10 | NP_004637.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPHS1 | ENST00000378910.10 | c.2869G>C | p.Val957Leu | missense_variant | 21/29 | 1 | NM_004646.4 | ENSP00000368190 | P2 | |
NPHS1 | ENST00000353632.6 | c.2869G>C | p.Val957Leu | missense_variant | 21/28 | 5 | ENSP00000343634 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152164Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00106 AC: 267AN: 251432Hom.: 0 AF XY: 0.000949 AC XY: 129AN XY: 135900
GnomAD4 exome AF: 0.000641 AC: 937AN: 1461886Hom.: 9 Cov.: 32 AF XY: 0.000652 AC XY: 474AN XY: 727244
GnomAD4 genome AF: 0.000716 AC: 109AN: 152282Hom.: 4 Cov.: 32 AF XY: 0.000846 AC XY: 63AN XY: 74454
ClinVar
Submissions by phenotype
Finnish congenital nephrotic syndrome Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Counsyl | Dec 15, 2017 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Oct 05, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Pars Genome Lab | May 18, 2021 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 14, 2016 | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | NPHS1: PM5, BP4, BS1 - |
Congenital nephrotic syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at